Morimatsu International Holdings Company Limited provided consolidated earnings guidance for the six months ended 30 June 2022. For the period, the group expects the consolidated revenue of the Group for the Reporting Period will record an increase of not less than 50% as compared to the corresponding period last year. Such expected increase is mainly attributable to the significant increase in orders from the pharmaceutical industry and raw materials of power battery (including mining and metallurgy) industry; and the consolidated net profit of the Group for the Reporting Period will record an increase of not less than 100% as compared to the corresponding period last year. Such expected increase is mainly attributable to the significant increase in revenue as a result of the expansion of the business scale of the Group and the enhanced production capacity. The Company is still in the process of finalising the interim results of the Group for the Reporting Period. The information contained in this announcement is only based on the preliminary assessment of the unaudited consolidated management accounts of the Group for the Reporting Period, which are subject to finalisation and other potential adjustments, if any, and have not been reviewed or confirmed by the auditors of the Company or the
audit committee of the Board. Shareholders and potential investors of the Company should refer to the interim results announcement of the Group for the Reporting Period, which is expected to be published on or around 18 August 2022.